Popular Trials
Behavioral Intervention
Collaborative Care for Post-Traumatic Epilepsy
Recruiting1 award
Winston-Salem, North Carolina
This trial is testing whether regular phone calls from a healthcare team can improve the quality of life for adults with post-traumatic epilepsy and anxiety or depression. The study will observe the effects over several months.
NMDA Receptor Antagonist
IV Ketamine for Epilepsy
Recruiting3 awardsPhase 2
New York, New York
This trial is testing small doses of ketamine to help people with epilepsy who don't respond to regular medications. Ketamine can help calm the brain and reduce seizures. The study will monitor patients' seizure activity and mood over time. Ketamine has been used in various settings for its ability to reduce seizures.
Popular Filters
Trials for Temporal Lobe Epilepsy Patients
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
Recruiting4 awardsPhase 3
Baltimore, Maryland
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Cenobamate for Seizures
Recruiting1 awardPhase 3
La Jolla, California
This trial tests cenobamate, a new medication for controlling seizures, in adults and adolescents with a specific type of epilepsy. The medication is taken regularly to stabilize brain activity and reduce seizures. Cenobamate has shown high effectiveness in previous studies.
Trials for Partial Seizures Patients
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
Recruiting4 awardsPhase 3
Baltimore, Maryland
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Cenobamate for Seizures
Recruiting1 awardPhase 3
La Jolla, California
This trial tests cenobamate, a new medication for controlling seizures, in adults and adolescents with a specific type of epilepsy. The medication is taken regularly to stabilize brain activity and reduce seizures. Cenobamate has shown high effectiveness in previous studies.
Phase 3 Trials
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
Recruiting4 awardsPhase 3
Baltimore, Maryland
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
Cenobamate for Epilepsy
Recruiting2 awardsPhase 3
La Jolla, California
This trial aims to ensure the safety of cenobamate, a seizure control medication, for patients who have already participated in a previous study. Cenobamate helps by calming overactive brain signals that cause seizures. Cenobamate is a new medication approved by the FDA in 2019 for the treatment of focal-onset seizures in adults.
Cenobamate for Seizures
Recruiting1 awardPhase 3
La Jolla, California
This trial tests cenobamate, a new medication for controlling seizures, in adults and adolescents with a specific type of epilepsy. The medication is taken regularly to stabilize brain activity and reduce seizures. Cenobamate has shown high effectiveness in previous studies.
Antiepileptic Drug
Brivaracetam for Absence Epilepsy
Recruiting1 awardPhase 3
Orlando, Florida
This trial is testing if the drug brivaracetam, used alone, is safe and effective for children and young adults aged 2 to 25 with certain types of epilepsy. The drug works by helping to control brain activity to prevent seizures.
Trials With No Placebo
Dietary Intervention
Ketogenic Diet vs Medication for Childhood Absence Epilepsy
Recruiting4 awardsPhase 3
Baltimore, Maryland
This trial is to assess if the modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy, as compared to a group of children in which the parents have declined and chose to start anticonvulsant medications.
AMPA Receptor Antagonist
Perampanel for Pediatric Epilepsy
Recruiting1 awardPhase 2
Los Angeles, California
This trial will study the effects of perampanel on seizure frequency in children with epileptic syndrome and partial-onset seizures. They will measure the 50% responder rate during the maintenance period of the study.
Cenobamate for Epilepsy
Recruiting2 awardsPhase 3
La Jolla, California
This trial aims to ensure the safety of cenobamate, a seizure control medication, for patients who have already participated in a previous study. Cenobamate helps by calming overactive brain signals that cause seizures. Cenobamate is a new medication approved by the FDA in 2019 for the treatment of focal-onset seizures in adults.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.